Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the role, the safety and the effectiveness of
Intravitreal Bevacizumab injections as an adjunct to vitrectomy in the management of severe
proliferative diabetic retinopathy.
Phase:
Phase 4
Details
Lead Sponsor:
Second University of Naples University of Campania "Luigi Vanvitelli"